Found: 8
Select item for more details and to access through your institution.
Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1221, doi. 10.1111/dom.14970
- By:
- Publication type:
- Article
Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open‐label, randomized controlled BEYOND‐V trial
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1957, doi. 10.1111/dom.14780
- By:
- Publication type:
- Article
Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug‐naive: A multicentre, randomized, open‐label, prospective study (ACADEMIC)
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 991, doi. 10.1111/dom.14661
- By:
- Publication type:
- Article
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 838, doi. 10.1111/dom.13967
- By:
- Publication type:
- Article
Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2359, doi. 10.1007/s13300-021-01112-z
- By:
- Publication type:
- Article
730-P: Basal Insulin Regimen vs. Twice-Daily Premix Insulin Regimen after Short-Term Intensive Insulin Therapy (SIT) in Patients with Type 2 Diabetes (T2D): A Multicenter, Open-Label Randomized Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-730-P
- By:
- Publication type:
- Article
721-P: Efficacy and Safety of Basal-First Titration Order in Patients with Type 2 Diabetes (T2D) Receiving Short-Term Intensive Insulin Therapy (SIT).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-721-P
- By:
- Publication type:
- Article
1102-P: High vs. Standard Starting Dose of Insulin Glargine 100 U/ml in Patients with Overweight/Obesity and Type 2 Diabetes Uncontrolled with Oral Antidiabetic Drugs in China: A Multicenter, Open-Label Randomized Controlled Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1102-P
- By:
- Publication type:
- Article